AYT
0.003
50%
SKN
0.003
-25%
ARV
0.004
33.3%
M96
0.007
-22.2%
OMG
0.008
33.3%
FAU
0.008
-20%
SPX
0.004
33.3%
OAK
0.06
-20%
SRJ
0.009
28.6%
ACS
0.19
-17.4%
NTI
0.015
25%
AAJ
0.005
-16.7%
ZEU
0.005
25%
BNL
0.005
-16.7%
RVT
0.135
22.7%
VIT
0.026
-16.1%
CNJ
0.011
22.2%
CHM
0.011
-15.4%
EV1
0.011
22.2%
RLF
0.029
-14.7%
TMS
0.011
22.2%
ADN
0.006
-14.3%
TOR
0.265
20.5%
EMU
0.018
-14.3%
AUR
0.018
20%
ERL
0.006
-14.3%
COY
0.006
20%
JGH
0.067
-14.1%
IPD
0.006
20%
ESR
0.031
-13.9%
TIO
0.12
20%
VR1
0.019
-13.6%
BDX
0.062
19.2%
49M
0.1
-13%
AMD
0.013
18.2%
FCT
0.007
-12.5%
W2V
0.055
17%
RAG
0.022
-12%
AEV
0.007
16.7%
RCR
0.015
-11.8%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AVITA Medical (ASX:AVH) signed an exclusive 5 year distribution agreement with Stedical Scientific

AVITA Medical (ASX:AVH) signed an exclusive five year distribution agreement with Stedical Scientific, to commercialise PermeaDerm® Biosynthetic Wound Matrix in the U.S. The matrix is cleared by the U.S. FDA and used for a variety of injuries | https://announcements.asx.com.au/asxpdf/20240111/pdf/05zbp446ftpyw0.pdf #FDA #PermeaDerm #AVH